MAR001

N/A

Report date: 2024/07/03 10:39:38

Base Information

Drug NameMAR001
Drug Alias NameMAR001MAR-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Angiopoietin-related protein 4
TargetsAngiopoietin-related protein 4
Therapy Area/IndicationsHypertriglyceridemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNew Zealand +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMareas Therapeutic Services Inc
China Registration ClassN/A

Develop Information

Active CompaniesMareas Therapeutic Services Inc
Inactive CompaniesN/A
Active IndicationsHypertriglyceridemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A